COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #11 of 230
4/12 Late treatment study
Barbosa et al., Preprint (Preprint)
Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study
Source   PDF   Share   Tweet
Small retrospective study with 63 patients (32 treated with HCQ), showing no effectiveness, however the baseline state of each arm significantly differs.
This preprint was submitted to NEJM but has not been published several months later.

Barbosa et al., 4/12/2020, retrospective, USA, North America, preprint, 5 authors.
risk of death, 147.0% higher, RR 2.47, p = 0.58, treatment 2 of 17 (11.8%), control 1 of 21 (4.8%).
Details of all 230 studies    Meta analysis
Please send us corrections, updates, or comments.